OTC Healthcare in Saudi Arabia

June 20, 2007 - PRLog -- Get insight into trends in market performance
Pinpoint growth sectors and identify factors driving change
Identify market and brand leaders and understand the competitive environment
Product coverage

Adult mouthcare; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; Vitamins and dietary supplements; Wound treatments

Table of contents

OTC HEALTHCARE - SAUDI ARABIA : MARKET INSIGHT

EXECUTIVE SUMMARY

OPERATING ENVIRONMENT

OTC Registration and Classification

Vitamins & Dietary Supplements Registration and Classification

Advertising

Packaging and Labelling

Distribution

De-listing or De-reimbursement

Traditional Remedies

Homeopathy

Generics

Consumer Expenditure on Health Goods and Medical Services

Table 1 Consumer Expenditure on Health Goods and Medical Services 2000-2005

Life Expectancy

Table 2 Life Expectancy at Birth 2000-2005

OTC HEALTHCARE SALES

Market Performance

Table 3 Sales of OTC Healthcare by Sector: Value 2000-2005

Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2000-2005

Switches

Table 5 OTC Healthcare Switches

Competitive Environment

Table 6 OTC Healthcare Company Shares by Retail Value 2001-2005

Table 7 OTC Healthcare Brand Shares by Retail Value 2002-2005

Retail Distribution

Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2000/2005

Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2005

Retailer Activity and Private Label Trends

Forecast Market Performance

Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2005-2010

Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2005-2010

DEFINITIONS

OTC HEALTHCARE - SAUDI ARABIA : LOCAL COMPANY PROFILES

GLAXO SAUDI ARABIA LTD - OTC HEALTHCARE - SAUDI ARABIA

COMPANY BACKGROUND

RECENT NEWS

Summary 1 Summary - Glaxo Saudi Arabia Ltd/GlaxoSmithKline: Operational Indicators 2004

PRODUCTION CAPACITY

JULPHAR GULF PHARMACEUTICALS - OTC HEALTHCARE - SAUDI ARABIA

COMPANY BACKGROUND

RECENT NEWS

Summary 2 Summary - Julphar: Operational Indicators 2004

PRODUCTION CAPACITY

SAUDI PHARMACEUTICAL INDUSTRIES & MEDICAL APPLIANCES CO (SPIMACO) - OTC HEALTHCARE - SAUDI ARABIA

COMPANY BACKGROUND

RECENT NEWS

Summary 3 Summary - SPIMACO: Operational Indicators 2004

PRODUCTION CAPACITY

TABUK PHARMACEUTICAL MANUFACTURING CO - OTC HEALTHCARE - SAUDI ARABIA

COMPANY BACKGROUND

RECENT NEWS

Summary 4 Summary - Tabuk Pharmaceutical Manufacturing Co: Operational Indicators 2004

PRODUCTION CAPACITY

ANALGESICS - SAUDI ARABIA : SECTOR BRIEFING

SECTOR PERFORMANCE

2005 headlines

Price increases, better distribution and advertising boost sales at healthier rate in 2005

GlaxoSmithKline’s share down slightly due to withdrawal of batches of Panadol Extra

SPIMACO second with good gains achieved in 2005 from Fevadol and Sapofen

Strong presence for foreign multinationals: Parke-Davis, Ciba-Geigy and Janssen Cilag

Adult analgesics

Child-specific analgesics

Topical analgesics

Forecast performance: forecast period sales to slow down due to stability of unit prices and maturity in largest subsectors

Table 12 Sales of Analgesics by Subsector: Value 2000-2005

Table 13 Sales of Analgesics by Subsector: % Value Growth 2000-2005

Table 14 Analgesics Company Shares by Retail Value 2001-2005

Table 15 Analgesics Brand Shares by Retail Value 2002-2005

Summary 5 Summary - Analgesics: New Product Launches 2004-2005

Table 16 Forecast Sales of Analgesics by Subsector: Value 2005-2010

Table 17 Forecast Sales of Analgesics by Subsector: % Value Growth 2005-2010

TOPICAL ANALGESICS BY HERBAL/STANDARD SPLIT

Table 18 Herbal vs Standard Topical Analgesics 2000/2005

COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES - SAUDI ARABIA : SECTOR BRIEFING

SECTOR PERFORMANCE

2005 headlines

Value sales peaked in 2005 due to price increases, switching and new product launches

Switching, high incidence of allergy and high unit prices boost sales of systemic antihistamines/allergy remedies

Pharyngeal preparations retains its position as the most dynamic subsector in 2005

New innovations continued to stimulate sales of combination products in 2005

Medicated confectionery boosted by mainstream products with sales up steadily in 2005

SPIMACO confirms its leading position and gains share in 2005

Novartis benefits from withdrawals and gains share with Otrivin, Otrinol and Orofar

Strong presence for multinationals

Forecast performance: Sales to continue to grow at the same healthy rate, driven by the same factors of the review period

Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2000-2005

Table 20 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2000-2005

Table 21 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Retail Value 2001-2005

Table 22 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Retail Value 2002-2005

Summary 6 Summary - Cough, Cold and Allergy (Hay Fever) Remedies: New Product Launches 2004-2005

Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2005-2010

Table 24 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2005-2010

COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES BY HERBAL/STANDARD SPLIT

Table 25 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2000/2005

DECONGESTANTS PERFORMANCE

For more information, Please visit :
http://www.bharatbook.com/bookdetail.asp?bookid=21921&pub...=

Website: www.bharatbook.com